Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Milestone Pharmaceuticals Inc
(NQ:
MIST
)
1.470
+0.030 (+2.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Milestone Pharmaceuticals Inc
< Previous
1
2
Next >
MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q2 2024
August 09, 2024
MIST stock results show that Milestone Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q1 2024
May 13, 2024
MIST stock results show that Milestone Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
MIST Stock Earnings: Milestone Pharmaceuticals Misses EPS for Q4 2023
March 21, 2024
MIST stock results show that Milestone Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Milestone Pharmaceuticals: Q4 Earnings Insights
March 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 29, 2024
Via
Benzinga
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
February 29, 2024
Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and
Via
Benzinga
Why Milestone Pharmaceuticals (MIST) Stock Is Rising
February 26, 2024
Milestone Pharmaceuticals shares are trading higher by 19.4% Monday morning. The company announced plans to resubmit the NDA for etripamil to the FDA.
Via
Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 29, 2024
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!
Via
InvestorPlace
Recap: Milestone Pharmaceuticals Q3 Earnings
November 13, 2023
Via
Benzinga
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 26, 2024
Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 26, 2024
Via
Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January
January 02, 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Analyst Expectations for Milestone Pharmaceuticals's Future
June 20, 2023
Via
Benzinga
Expert Ratings for Milestone Pharmaceuticals
May 23, 2023
Via
Benzinga
Milestone Pharmaceuticals: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Milestone Pharmaceuticals's Return On Capital Employed Overview
March 30, 2023
Via
Benzinga
Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
December 27, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
December 26, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.50% to 37,574.66 while the NASDAQ rose 0.50% to 15,068.50. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 26, 2023
Via
Benzinga
Crude Oil Rises Over 3%; US Home Prices Increase In October
December 26, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,511.87 while the NASDAQ rose 0.43% to 15,057.13. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 26, 2023
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth...
Via
Benzinga
Why Is Heart Disease-Focused Milestone Pharmaceuticals Stock Plummeting Today?
December 26, 2023
Milestone Pharmaceuticals Inc (NASDAQ: MIST) announced Tuesday that the Company received a Refusal to File (RTF) letter from the FDA for the New Drug Application seeking approval for self-administered...
Via
Benzinga
Exposures
Product Safety
Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
December 26, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.09% to 37,418.31 while the NASDAQ rose...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 19, 2023
Via
Benzinga
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 28, 2023
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023
June 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 05, 2022
Via
Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
October 18, 2022
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.